FAEGRE DRINKER BIDDLE & REATH LLP lobbying for NATIONAL ASSOCIATION OF BOARDS OF PHARMACY

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$30,000.00

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Lobbyists on this filing 3

MEGAN SUSSMAN HERBER

Previously held: Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA)
ELLIOT VICE

Previously held: Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009-2010
MAYA BOLTER

Previously held: Legislative Intern, Representative Dean Phillips (D-MN-03), September 2019-December 2019

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

Centers For Medicare and Medicaid Services (CMS)
HOUSE OF REPRESENTATIVES
SENATE
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 929
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
HR 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025

Lobbying activity 2

Health Issues

Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.

Pharmacy

Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.